Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06082661 · ClinicalTrials.gov registry record
Blood Collection for COM/BSBS
A clinical trial of Healthy, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06082661: Recruiting study of Healthy, sponsored by University of Central Florida.
NCT06082661 is a study of Healthy that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 5,000 participants, above the 643-participant average among 1,090 other Healthy trials with a reported enrollment target (678% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06082661, a study of Healthy, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this biospecimen collection protocol is the acquisition of blood from adult volunteers. These biospecimens will be transferred to the College of Medicine (COM)/Burnett School of Biomedical Sciences (BSBS) research scientists and their research teams for testing according to their separate IRB-approved/exempted protocols. These separate IRBapproved protocols cannot be for genetic testing.
Primary Outcome
This is a non-clinical, biospecimen collection study.
Conditions Studied
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-06-23 |
| Est. Completion | 2027-06 |
What NCT06082661 shows while recruiting
NCT06082661 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 643-participant average among 1,090 other Healthy trials with a reported enrollment target (678% higher).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT06082661 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06082661 about?
NCT06082661 is a clinical study titled "Blood Collection for COM/BSBS". The objective of this biospecimen collection protocol is the acquisition of blood from adult volunteers. These biospecimens will be transferred to the College of Medicine (COM)/Burnett School of Biomedical Sciences (BSBS) research scientists and their research teams for testing according to their se...
What is the current status of trial NCT06082661?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-06-23. Estimated completion is 2027-06.
What conditions does trial NCT06082661 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT06082661?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06082661 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06082661's enrollment target sits among peer trials
5,000 13th of 1090 higher than 1,077 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI